Remove tag better-therapeutics
article thumbnail

A broad range of unmet needs remains in the immuno-oncology space

Pharmaceutical Technology

Immuno-oncology (IO) agents have transformed the cancer therapeutics landscape, driving long-term remissions in a subset of patients who historically had limited options. IO agents include the classes of immune checkpoint modulators, cell therapies, bispecific antibodies, oncolytic viruses, therapeutic vaccines, and cytokines.

article thumbnail

bluebird bio to split into oncology and gene therapy specialists

pharmaphorum

The companies will be better equipped to deliver on goals and operations will be streamlined and simplified. They will also be better at raising money with tailored investment theses and increased strategic flexibility. million price tag.

FDA 66
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The “Graziella Molinari Women in Pharma Award” Announced for 2022 Edition at the ISPE Italy Affiliate

ISPE

In the Pharma sector, women's shares are better represented than in other sectors. Winner of the ISPE Italy Affiliate’s Women in Pharma® Graziella Molinari Award in 2021, thanks to her project for the inclusion of #smart tags in a site production in order to improve not only efficiency, but also quality and compliance in a 4.0

98
article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Released on April 12, the report focuses on bluebird bio’s lovotibeglogene autotemcel and Vertex Pharmaceuticals and CRISPR Therapeutics’ exagamglogene autotemcel or exa-cel and their potential use in treating sickle cell disease. Still, comparing the two therapies remains difficult, with ICER rating the evidence as insufficient.

FDA 59
article thumbnail

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

pharmaphorum

This evolution is leading to additional health benefits and health gains, but they are accompanied by major concerns, as very high price tags raise questions about their affordability.”. In recent years, revolutionary medicines have come with price tags to match, but this is simply a symptom of our current model. Finding solutions.

article thumbnail

Addressing Cultural Competency: Healthcare for Refugees & Minority Populations

Colors Make me Happy

So when Fatima learned of an opportunity to move to the United States, she knew it was a chance for a better life. Ironically, refugees relocate because of a desire to live better lives, so the simultaneous challenge of incorporating good health should be a natural symbiosis.

article thumbnail

PharmDs – Crucial to Chronic Care Management Services: A Doctor’s Perspective

PharmD Live

They advised on starting doses of weight and renally dosed medication, so the patient received the correct medication within the appropriate therapeutic window. 75% of providers report that their EHR allows them to deliver better patient care. 75% of providers report that their EHR allows them to deliver better patient care.